More than 90% suspected muscular dystrophy (MD) can be confirmed with multiplex ligation-dependent probe amplification (MLPA) combined with targeted panel, although there are a few that cannot be identified. A total of 312 suspected MD patients were enrolled into the study. The MLPA combined with a targeted myopathy panel were performed. Patients with negative results were subjected to whole exome sequencing (WES), whole genome sequencing (WGS), and/or RNA sequencing (RNA-seq). A total of 275 cases were diagnosed as Duchenne/Becker muscular dystrophy (DMD/BMD) and 20 cases were other types of myopathy or nonmuscular diseases. Six female DMD/BMD patients suffered from varying degrees of typical DMD-like symptoms and 2 others were suspected to be gonadal mosaicism. The systematic application of WES, WGS, and/or RNA-seq highlighted the need for the detection of variants missed by the current standard diagnostic procedures. The identification of female patients and mosaic carriers was crucial to predict the risk of recurrence and allow for optimal genetic counseling.
BirnkrantDJBushbyKBannCM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17(3):251-267.
5.
SalmaninejadAJafari AbarghanYBozorg QomiS, et al. Common therapeutic advances for Duchenne muscular dystrophy (DMD). Int J Neurosci. 2021;131(4):370-389.
6.
OkuboMMinamiNGotoK, et al. Genetic diagnosis of Duchenne/Becker muscular dystrophy using next-generation sequencing: validation analysis of DMD mutations. J Hum Genet. 2016;61(6):483-489.
7.
KimSHHongSYLeeMJ, et al. Prenatal diagnosis of de novo DMD duplication by multiplex ligation-dependent probe amplification (MLPA) after noninvasive prenatal screening (NIPS) at 11 gestational weeks. Taiwan J Obstet Gynecol. 2021;60(3):570-573.
8.
WangDGaoMZhangK, et al. Molecular genetics analysis of 70 Chinese families with muscular dystrophy using multiplex ligation-dependent probe amplification and next-generation sequencing. Front Pharmacol. 2019;10:814.
9.
NiuHHTaoDYChengSQ.[A predictive analysis of the association between clinical phenotypes and genotypes in children with Becker muscular dystrophy/Duchenne muscular dystrophy]. Zhongguo Dang Dai Er Ke Za Zhi. 2020;22(6):602-607.
10.
KongXZhongXLiuLCuiSYangYKongL.Genetic analysis of 1051 Chinese families with Duchenne/Becker muscular dystrophy. BMC Med Genet. 2019;20(1):139.
11.
ToksoyGDurmusHAghayevA, et al. Mutation spectrum of 260 dystrophinopathy patients from Turkey and important highlights for genetic counseling. Neuromuscul Disord. 2019;29(8):601-613.
12.
ZhongJXuTChenGLiaoHZhangJLanD.Genetic analysis of the dystrophin gene in children with Duchenne and Becker muscular dystrophies. Muscle Nerve. 2017;56(1):117-121.
13.
ZamaniGRMohammadiMFTavasoliAR, et al. Genetic analysis of Forty MLPA-negative Duchenne muscular dystrophy patients by whole-exome sequencing. J Mol Neurosci. 2022;72(5):1098-1107.
14.
AlfaresAAlorainiTSubaieLA, et al. Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing. Genet Med. 2018;20(11):1328-1333.
15.
Basel-SalmonLOrensteinNMarkus-BustaniK, et al. Improved diagnostics by exome sequencing following raw data reevaluation by clinical geneticists involved in the medical care of the individuals tested. Genet Med. 2019;21(6):1443-1451.
16.
WengerAMGuturuHBernsteinJABejeranoG.Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providers. Genet Med. 2017;19(2):209-214.
17.
EwansLJSchofieldDShresthaR, et al. Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders. Genet Med. 2018;20(12):1564-1574.
18.
RajagopalanRGilbertMAMcEldrewDA, et al. Genome sequencing increases diagnostic yield in clinically diagnosed Alagille syndrome patients with previously negative test results. Genet Med. 2021;23(2):323-330.
19.
BarseghyanHTangWWangRT, et al. Next-generation mapping: a novel approach for detection of pathogenic structural variants with a potential utility in clinical diagnosis. Genome Med. 2017;9(1):90.
20.
Schluth-BolardCDiguetFChatronN, et al. Whole genome paired-end sequencing elucidates functional and phenotypic consequences of balanced chromosomal rearrangement in patients with developmental disorders. J Med Genet. 2019;56(8):526-535.
21.
LionelACCostainGMonfaredN, et al. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. Genet Med. 2018;20(4):435-443.
22.
GonorazkyHLiangMCummingsB, et al. RNAseq analysis for the diagnosis of muscular dystrophy. Ann Clin Transl Neurol. 2016;3(1):55-60.
23.
GonorazkyHDNaumenkoSRamaniAK, et al. Expanding the boundaries of RNA sequencing as a diagnostic tool for rare Mendelian disease. Am J Hum Genet. 2019;104(3):466-483.
24.
ZhongJXieYDangYZhangJSongYLanD.Use of RNA-sequencing to detect abnormal transcription of the collagen α‑2 (VI) chain gene that can lead to Bethlem myopathy. Int J Mol Med. 2021;47(3):28.
25.
GuoRZhuGZhuH, et al. DMD mutation spectrum analysis in 613 Chinese patients with dystrophinopathy. J Hum Genet. 2015;60(8):435-442.
26.
TomarSMoorthyVSethiR, et al. Mutational spectrum of dystrophinopathies in Singapore: insights for genetic diagnosis and precision therapy. Am J Med Genet C Semin Med Genet. 2019;181(2):230-244.
27.
MaPZhangSZhangH, et al. Comprehensive genetic characteristics of dystrophinopathies in China. Orphanet J Rare Dis. 2018;13(1):109.
28.
MonacoAPBertelsonCJLiechti-GallatiSMoserHKunkelLM.An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988;2(1):90-95.
29.
WeinNAlfanoLFlaniganKM.Genetics and emerging treatments for Duchenne and Becker muscular dystrophy. Pediatr Clin North Am. 2015;62(3):723-742.
30.
ElhawaryNAShawkyRMHashemN.Frameshift deletion mechanisms in Egyptian Duchenne and Becker muscular dystrophy families. Mol Cells. 2004;18(2):141-149.
31.
KerrTPSewryCARobbSARobertsRG.Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay. Hum Genet. 2001;109(4):402-407.
32.
GualandiFTrabanelliCRimessiP, et al. Multiple exon skipping and RNA circularisation contribute to the severe phenotypic expression of exon 5 dystrophin deletion. J Med Genet. 2003;40(8):e100.
33.
CummingsBBMarshallJLTukiainenT, et al. Improving genetic diagnosis in Mendelian disease with transcriptome sequencing. Sci Transl Med. 2017;9(386):eaal5209.
34.
ZhuFZhangFHuLLiuHLiY.Integrated genome and transcriptome sequencing to solve a neuromuscular puzzle: Miyoshi muscular dystrophy and early onset primary dystonia in siblings of the same family. Front Genet. 2021;12:672906.
35.
ZhongJXieYBhandariV, et al. Clinical and genetic characteristics of female dystrophinopathy carriers. Mol Med Rep. 2019;19(4):3035-3044.
36.
ChenJZhengHWangZ, et al. A female carrier of a novel DMD mutation with slightly skewed X-chromosome inactivation shows a suspected case of Becker muscular dystrophy in a Chinese family. Mol Genet Genomics. 2021;296(3):541-549.
37.
VermaSGoyalPBeamCShahD.Turner syndrome and Duchenne muscular dystrophy. Muscle Nerve. 2017;56(2):E12-E15.
38.
FerrierPBamatterFKleinD.Muscular dystrophy (Duchenne) in a girl with Turner’s syndrome. J Med Genet. 1965;2(1):38-46.
39.
BortoliniERda SilvaDMChequerRSVianna-MorganteAMZatzM.Duchenne muscular dystrophy in a girl with a 45,X/46,XX/47,XXX chromosome constitution. Am J Med Genet. 1986;25(2):239-243.
40.
SanoMSaitoFYamamotoKTonomuraATsukagoshiH.Duchenne muscular dystrophy in a female with 45,X/46,XX chromosome constitution. Jinrui Idengaku Zasshi. 1987;32(3):257-262.
41.
Passos-BuenoMRLimaMAZatzM.Estimate of germinal mosaicism in Duchenne muscular dystrophy. J Med Genet. 1990;27(11):727-728.
42.
de HoonBMonkhorstKRiegmanPLavenJSGribnauJ.Buccal swab as a reliable predictor for X inactivation ratio in inaccessible tissues. J Med Genet. 2015;52(11):784-790.
43.
LinYXuAZengC, et al. Somatic and germline FOXP3 mosaicism in the mother of a boy with IPEX syndrome. Eur J Immunol. 2018;48(5):885-887.
44.
KarolakJALiuQXieNG, et al. Highly sensitive blocker displacement amplification and droplet digital PCR reveal low-level parental FOXF1 somatic mosaicism in families with alveolar capillary dysplasia with misalignment of pulmonary veins. J Mol Diagn. 2020;22(4):447-456.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
